{"id":"https://openalex.org/W1978337075","doi":"https://doi.org/10.1371/journal.pone.0115476","title":"Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization","display_name":"Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization","publication_year":2015,"publication_date":"2015-01-28","ids":{"openalex":"https://openalex.org/W1978337075","doi":"https://doi.org/10.1371/journal.pone.0115476","mag":"1978337075","pmid":"https://pubmed.ncbi.nlm.nih.gov/25629161","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4309450"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0115476","doi":"https://doi.org/10.1371/journal.pone.0115476","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0115476","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115476&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115476&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071330243","display_name":"Surender Khurana","orcid":"https://orcid.org/0000-0002-0593-7965","observed_orcids":["https://orcid.org/0000-0002-0593-7965"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Surender Khurana","raw_affiliation_strings":["Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007743870","display_name":"Elizabeth M. Coyle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth M. Coyle","raw_affiliation_strings":["Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019476028","display_name":"Jody F. Manischewitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jody Manischewitz","raw_affiliation_strings":["Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111585243","display_name":"Lisa R. King","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa R. King","raw_affiliation_strings":["Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111630865","display_name":"Glenn Y. Ishioka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141015","display_name":"PaxVax (United States)","ror":"https://ror.org/0425hsv68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Glenn Ishioka","raw_affiliation_strings":["PaxVax, San Diego, CA, United States of America, 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PaxVax, San Diego, CA, United States of America, 92121","institution_ids":["https://openalex.org/I4210141015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020934619","display_name":"Jeff Alexander","orcid":"https://orcid.org/0000-0001-7066-3780","observed_orcids":["https://orcid.org/0000-0001-7066-3780"]},"institutions":[{"id":"https://openalex.org/I4210141015","display_name":"PaxVax (United States)","ror":"https://ror.org/0425hsv68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeff Alexander","raw_affiliation_strings":["PaxVax, San Diego, CA, United States of America, 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PaxVax, San Diego, CA, United States of America, 92121","institution_ids":["https://openalex.org/I4210141015"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jon Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141015","display_name":"PaxVax (United States)","ror":"https://ror.org/0425hsv68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jon Smith","raw_affiliation_strings":["PaxVax, San Diego, CA, United States of America, 92121"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PaxVax, San Diego, CA, United States of America, 92121","institution_ids":["https://openalex.org/I4210141015"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001360183","display_name":"Marc Gurwith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141015","display_name":"PaxVax (United States)","ror":"https://ror.org/0425hsv68","country_code":"US","type":"company","lineage":["https://openalex.org/I4210141015"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Gurwith","raw_affiliation_strings":["PaxVax, Redwood City, CA, United States of America, 94063"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PaxVax, Redwood City, CA, United States of America, 94063","institution_ids":["https://openalex.org/I4210141015"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020973283","display_name":"Hana Golding","orcid":"https://orcid.org/0000-0001-8116-694X","observed_orcids":["https://orcid.org/0000-0001-8116-694X"]},"institutions":[{"id":"https://openalex.org/I1318287680","display_name":"Center for Biologics Evaluation and Research","ror":"https://ror.org/02nr3fr97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1318287680","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Hana Golding","raw_affiliation_strings":["Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, Maryland, United States of America, 20903","institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5020973283","https://openalex.org/A5071330243"],"corresponding_institution_ids":["https://openalex.org/I1318287680","https://openalex.org/I1320320070"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":3.4032,"has_fulltext":true,"cited_by_count":25,"citation_normalized_percentile":{"value":0.92180965,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"10","issue":"1","first_page":"e0115476","last_page":"e0115476"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11135","display_name":"Virology and Viral Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/h5n1-avian-influenza","display_name":"H5N1 avian influenza","score":0.8410000205039978},{"id":"https://openalex.org/keywords/protein-subunit-vaccines","display_name":"subunit vaccine","score":0.5460000038146973},{"id":"https://openalex.org/keywords/affinity-maturation","display_name":"affinity maturation","score":0.8830000162124634},{"id":"https://openalex.org/keywords/cross-clade-neutralization","display_name":"cross-clade neutralization","score":0.8460000157356262},{"id":"https://openalex.org/keywords/hemagglutination-inhibition","display_name":"hemagglutination inhibition","score":0.8659999966621399},{"id":"https://openalex.org/keywords/memory-b-cells","display_name":"memory B cells","score":0.6359999775886536},{"id":"https://openalex.org/keywords/pandemic-influenza","display_name":"pandemic influenza","score":0.5239999890327454},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.7756998538970947},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7302004098892212},{"id":"https://openalex.org/C10389963","wikidata":"https://www.wikidata.org/wiki/Q848328","display_name":"Serotype","level":2,"score":0.6500284671783447},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6368541121482849},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.6048001646995544},{"id":"https://openalex.org/C519248777","wikidata":"https://www.wikidata.org/wiki/Q160122","display_name":"Influenza A virus subtype H5N1","level":3,"score":0.5813135504722595},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5750592947006226},{"id":"https://openalex.org/C44465124","wikidata":"https://www.wikidata.org/wiki/Q713623","display_name":"Clade","level":4,"score":0.5402315855026245},{"id":"https://openalex.org/C81444415","wikidata":"https://www.wikidata.org/wiki/Q7243535","display_name":"Priming (agriculture)","level":3,"score":0.4681304693222046},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2154693603515625},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18634074926376343},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.13932684063911438},{"id":"https://openalex.org/C90132467","wikidata":"https://www.wikidata.org/wiki/Q171184","display_name":"Phylogenetics","level":3,"score":0.12139669060707092},{"id":"https://openalex.org/C100701293","wikidata":"https://www.wikidata.org/wiki/Q193838","display_name":"Germination","level":2,"score":0.0},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000260","descriptor_name":"Adenoviruses, Human","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000915","descriptor_name":"Antibody Affinity","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005822","descriptor_name":"Genetic Vectors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007117","descriptor_name":"Immunization, Secondary","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007252","descriptor_name":"Influenza Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D022223","descriptor_name":"Vaccines, Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D053124","descriptor_name":"Influenza A Virus, H5N1 Subtype","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":false},{"descriptor_ui":"D053124","descriptor_name":"Influenza A Virus, H5N1 Subtype","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053124","descriptor_name":"Influenza A Virus, H5N1 Subtype","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1371/journal.pone.0115476","doi":"https://doi.org/10.1371/journal.pone.0115476","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0115476","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115476&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4309450","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4309450","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:25629161","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25629161","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:2f4a91ee8c2445f793525c6fccdf81f6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2f4a91ee8c2445f793525c6fccdf81f6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 10, Iss 1, p e0115476 (2015)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0115476","doi":"https://doi.org/10.1371/journal.pone.0115476","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0115476","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0115476&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1978337075.pdf","grobid_xml":"https://content.openalex.org/works/W1978337075.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1480661791","https://openalex.org/W1824220324","https://openalex.org/W1919993122","https://openalex.org/W1965145857","https://openalex.org/W1976348617","https://openalex.org/W1988796527","https://openalex.org/W2003205644","https://openalex.org/W2005355845","https://openalex.org/W2020544730","https://openalex.org/W2039341935","https://openalex.org/W2040454631","https://openalex.org/W2057647944","https://openalex.org/W2060680095","https://openalex.org/W2083824233","https://openalex.org/W2084437187","https://openalex.org/W2093138102","https://openalex.org/W2103783169","https://openalex.org/W2115473644","https://openalex.org/W2117365839","https://openalex.org/W2118362676","https://openalex.org/W2129973151","https://openalex.org/W2131170401","https://openalex.org/W2136931342","https://openalex.org/W2141190797","https://openalex.org/W2141710322","https://openalex.org/W2143588126","https://openalex.org/W2144563230","https://openalex.org/W2155467153","https://openalex.org/W2161221245","https://openalex.org/W2161344127","https://openalex.org/W2161784995","https://openalex.org/W2402287410","https://openalex.org/W4298094696"],"related_works":["https://openalex.org/W7100625441","https://openalex.org/W2090278516","https://openalex.org/W7099984064","https://openalex.org/W2141190797","https://openalex.org/W2050223302","https://openalex.org/W2211764956","https://openalex.org/W2497529148","https://openalex.org/W7099914913","https://openalex.org/W2157384064","https://openalex.org/W1993606696"],"abstract_inverted_index":{"A":[0],"Phase":[1],"I":[2],"trial":[3],"conducted":[4],"in":[5,60,163],"2009-2010":[6],"demonstrated":[7,140],"that":[8,131,141],"oral":[9,213],"vaccination":[10,135],"with":[11,18,51,65,127,169,226],"a":[12,44,52,89,199],"replication":[13],"competent":[14],"Ad4-H5":[15,75,165],"(A/Vietnam)":[16,56],"vector":[17],"dosages":[19],"ranging":[20],"from":[21,104,129,171],"107-1011":[22],"viral":[23],"particles":[24],"was":[25,86,123],"well":[26],"tolerated.":[27],"HA-specific":[28],"T-cell":[29],"responses":[30,40],"were":[31,41,160,178],"efficiently":[32],"induced,":[33],"but":[34],"very":[35],"limited":[36],"hemagglutination-inhibiting":[37],"(HI)":[38],"humoral":[39,83],"measured.":[42],"However,":[43],"single":[45],"boost":[46],"of":[47,74,80,100,152,158,201,212,230],"Ad4-H5-Vtn":[48,106],"vaccinated":[49],"individuals":[50,130],"unadjuvanted":[53],"licensed":[54],"H5N1":[55,134,205],"subunit":[57,133],"vaccine":[58,215],"resulted":[59],"superior":[61],"HI":[62],"titers":[63,193],"compared":[64,126,168],"unprimed":[66,173],"subjects.":[67],"In":[68],"the":[69,72,78,81,105,142,156,164,172,181,190,195,210],"current":[70],"study,":[71],"impact":[73],"priming":[76],"on":[77],"quality":[79],"polyclonal":[82,102],"immune":[84],"response":[85,232],"evaluated":[87],"using":[88],"real-time":[90],"kinetics":[91],"assay":[92],"by":[93],"surface":[94],"plasmon":[95],"resonance":[96],"(SPR).":[97],"Total":[98],"binding":[99],"serum":[101,153],"antibodies":[103,154],"primed":[107,166],"groups":[108,167],"against":[109,155,194,217],"both":[110],"homologous":[111,196],"H5N1-A/Vietnam/1194/2004":[112],"(clade":[113,118],"1)":[114],"and":[115,189,198,240],"heterologous":[116,202],"A/Indonesia-5/2005":[117],"2.1)":[119],"HA1":[120,157,185],"head":[121],"domain":[122],"significantly":[124,161],"higher":[125,162],"sera":[128],"received":[132],"alone.":[136],"SPR":[137],"measurements":[138],"also":[139],"antigen-antibody":[143],"complex":[144],"dissociation":[145],"rates":[146],"(a":[147],"surrogate":[148],"for":[149,184],"antibody":[150,182],"affinity)":[151],"H5N1-A/Vietnam":[159],"those":[170],"group.":[174],"Furthermore,":[175],"strong":[176],"correlations":[177],"observed":[179],"between":[180],"affinities":[183],"(but":[186],"not":[187],"HA2)":[188],"virus":[191],"neutralization":[192],"strain":[197],"panel":[200],"clade":[203],"2":[204],"strains.":[206],"These":[207],"findings":[208],"support":[209],"concept":[211],"prime-boost":[214],"approaches":[216],"pandemic":[218,235],"influenza":[219],"to":[220,233,238,242],"elicit":[221],"long-term":[222],"memory":[223],"B":[224],"cells":[225],"high":[227],"affinity":[228],"capable":[229],"rapid":[231],"variant":[234],"viruses":[236],"likely":[237],"emerge":[239],"adapt":[241],"human":[243],"transmissions.":[244]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}